Addictive illegal drugs: Structural neuroimaging

American Journal of Neuroradiology

Volumn 31, Issue 5, 2010, Pages 803-808

  Geibprasert, S ^a   Gallucci, M ^b   Krings, T ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b SAN SALVATORE HOSPITAL   (Italy)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; ANTITHROMBIN III; CANNABIS; COCAINE; CODEINE; DIAMORPHINE; DIHYDROMORPHINE; DOPAMINE; FENTANYL; GLUE; HYDROCODONE; INK; METHADONE; MORPHINE; MYELIN; OPIATE; OXYCODONE; PAINT; PROTEIN C; SEROTONIN 2A RECEPTOR; THINNER; THROMBOXANE; TOLUENE;

AGITATION; ALCOHOL CONSUMPTION; ANALGESIA; ATAXIA; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BEHAVIOR CHANGE; BLOOD VESSEL WALL; BRAIN ABSCESS; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN STEM; BRAIN VASOSPASM; CENTRAL NERVOUS SYSTEM; CEREBELLAR ATAXIA; CEREBELLUM; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; CRANIAL NERVE; DEMYELINATION; DENTATE GYRUS; DEPRESSION; DOPPLER ECHOGRAPHY; EMBOLISM; ENDOCARDITIS; ENERGY; EUPHORIA; FATIGUE; FRONTAL LOBE; GLIOSIS; GLOBUS PALLIDUS; HALLUCINATION; HEADACHE; HEARING LOSS; HEART INFARCTION; HEART OUTPUT; HEART RATE; HEMOSTASIS; HIPPOCAMPUS; HISTOPATHOLOGY; HYPERTENSION; HYPERTHERMIA; INTOXICATION; KIDNEY; LEUKOENCEPHALOPATHY; LIMBIC CORTEX; MENTAL DISEASE; MIOSIS; MUCOSA; MYALGIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OLIGODENDROGLIA; ORTHOSTATIC HYPOTENSION; PARIETAL LOBE; PARKINSON DISEASE; PONS; POSITRON EMISSION TOMOGRAPHY; PURKINJE CELL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SMOKING; SPASTICITY; STAPHYLOCOCCUS AUREUS; SUBSTANTIA NIGRA; SUPINE POSITION; SYSTEMATIC REVIEW; TACHYCARDIA; TEMPORAL LOBE; THALAMUS; THROMBOSIS; TRISMUS; VASCULITIS; VASOCONSTRICTION; VISUAL IMPAIRMENT; WHITE MATTER;

BRAIN DISEASES; CEREBRAL ANGIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77952327805     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1811     Document Type: Review

References (54)

1. Fowler JS, Volkow ND, Kassed CA, et al. Imaging the addictedhumanbrain. Sci Pract Perspect 2007;3:4-16
2. Gatley SJ, Volkow ND. Addiction and imaging of the living human brain. Drug Alcohol Depend 1998;51:97-108 (Pubitemid 28353759)
3. Lingford-Hughes AR, Davies SJ, McIver S, et al. Addiction. Br Med Bull 2003;65:209-222
4. Magalhaes AC. Functional magnetic resonance and spectroscopy in drug and substance abuse. Top Magn Reson Imaging 2005;16:247-251 (Pubitemid 43361874)
5. Mena JC, Cuellar H, Vargas D, et al. PET and SPECT in drug and substance abuse. Top Magn Reson Imaging 2005;16:253-256 (Pubitemid 43361875)
6. Moussouttas M. Cannabis use and cerebrovascular disease. Neurologist 2004;10:47-53
7. Chang L, Chronicle EP. Functional imaging studies in cannabis users. Neuroscientist 2007;13:422-432 (Pubitemid 47437933)
8. Quickfall J, Crockford D. Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 2006;18:318-332
9. Iversen L. Cannabis and the brain. Brain 2003;126:1252-1270
10. Mateo I, Pinedo A, Gomez-Beldarrain M, et al. Recurrent stroke associated with cannabis use. J Neurol Neurosurg Psychiatry 2005;76:435-437 (Pubitemid 40299142)
11. Mathew RJ, Wilson WH, Humphreys DF, et al. Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab 1992;12:750-758
12. O'Leary DS, Block RI, Koeppel JA, et al. Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 2002;26:802-816
13. Herning RI, Better WE, Tate K, et al. Marijuana abusers are at increased risk for stroke: preliminary evidence from cerebrovascular perfusion data. Ann N Y Acad Sci 2001;939:413-415 (Pubitemid 32620094)
14. Aydin K, Sencer S, Ogel K, et al. Single-voxel proton MR spectroscopy in toluene abuse. Magn Reson Imaging 2003;21:777-785 (Pubitemid 37259905)
15. Yamanouchi N, Okada S, Kodama K, et al. White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol 1995;16:1643-1649
16. Aydin K, Sencer S, Demir T, et al. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol 2002;23:1173-1179
17. King MD. Neurological sequelae of toluene abuse. Hum Toxicol 1982;1:281-287
18. Lazar RB, Ho SU, Melen O, et al. Multifocal central nervous system damage caused by toluene abuse. Neurology 1983;33:1337-1340 (Pubitemid 13021198)
19. Unger E, Alexander A, Fritz T, et al. Toluene abuse: physical basis for hypointensity of the basal ganglia on T2-weighted MR images. Radiology 1994;193: 473-476 (Pubitemid 24338336)
20. Kamran S, Bakshi R. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images. Neuroradiology 1998;40:519-521 (Pubitemid 28396020)
21. Williams MJ, Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008;33:1779-1797
22. Brown E, Prager J, Lee HY, et al. CNS complications of cocaine abuse: prevalence, pathophysiology, and neuroradiology. AJR Am J Roentgenol 1992;159:137-147
23. Nolte KB, Gelman BB. Intracerebral hemorrhage associated with cocaine abuse. Arch Pathol Lab Med 1989;113:812-813 (Pubitemid 19173019)
24. McEvoy AW, Kitchen ND, Thomas DG. Intracerebral haemorrhage and drug abuse in young adults. Br J Neurosurg 2000;14:449-454
25. Pozzi M, Roccatagliata D, Sterzi R. Drug abuse and intracranial hemorrhage. Neurol Sci 2008;29 (suppl 2):S269-270
26. Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med 1990;323:699-704
27. Krendel DA, Ditter SM, Frankel MR, et al. Biopsy-proven cerebral vasculitis associated with cocaine abuse. Neurology 1990;40:1092-1094 (Pubitemid 20213977)
28. Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 1996;46:1291-1296
29. Kaufman MJ, Levin JM, Ross MH, et al. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 1998;279:376-380 (Pubitemid 28133867)
30. Rojas R, Riascos R, Vargas D, et al. Neuroimaging in drug and substance abuse. Part I. Cocaine, cannabis, and ecstasy. Top Magn Reson Imaging 2005;16:231-238 (Pubitemid 43361872)
31. Hurley RA, Reneman L, Taber KH. Ecstasy in the brain: a model for neuroimaging. J Neuropsychiatry Clin Neurosci 2002;14:125-129
32. Morgan MJ. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl) 2000;152:230-248
33. Green AR, Mechan AO, Elliott JM, et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 2003;55:463-508
34. Reneman L, Habraken JB, Majoie CB, et al. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol 2000;21:1001-1007 (Pubitemid 30390531)
35. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992;340:384-387
36. Spatt J, Glawar B, Mamoli B. A pure amnestic syndrome after MDMA ("ecstasy") ingestion. J Neurol Neurosurg Psychiatry 1997;62:418-419 (Pubitemid 27199123)
37. Squier MV, Jalloh S, Hilton-Jones D, et al. Death after ecstasy ingestion: neuropathological findings. J Neurol Neurosurg Psychiatry 1995;58:756
38. Bae SC, Lyoo IK, Sung YH, et al. Increased white matter hyperintensities in male methamphetamine abusers. Drug Alcohol Depend 2006;81:83-88
39. Borne J, Riascos R, Cuellar H, et al. Neuroimaging in drug and substance abuse. Part II. Opioids and solvents. Top Magn Reson Imaging 2005;16:239-245 (Pubitemid 43361873)
40. Trescot AM, Datta S, Lee M, et al. Opioid pharmacology. Pain Physician 2008;11(2 suppl):S133-153
41. Buttner A, Mall G, Penning R, et al. The neuropathology of heroin abuse. Forensic Sci Int 2000;113:435-442
42. Brust JC, Richter RW. Stroke associated with addiction to heroin. J Neurol Neurosurg Psychiatry 1976;39:194-199
43. Volkow ND, Valentine A, Kulkarni M. Radiological and neurological changes in the drug abuse patient: a study with MRI. J Neuroradiol 1988;15:288-293
44. Andersen SN, Skullerud K. Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci Int 1999;102:51-59
45. Bartlett E, Mikulis DJ. Chasing "chasing the dragon" with MRI: leukoencephalopathy in drug abuse. Br J Radiol 2005;78:997-1004 (Pubitemid 41684027)
46. Keogh CF, Andrews GT, Spacey SD, et al. Neuroimaging features of heroin inhalation toxicity: "chasing the dragon." AJR Am J Roentgenol 2003;180:847-850
47. Offiah C, Hall E. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy. Clin Radiol 2008;63:146-152
48. Schiffer D, Brignolio F, Giordana MT, et al. Spongiform encephalopathy in addicts inhaling pre-heated heroin. Clin Neuropathol 1985;4:174-180
49. Wolters EC, van Wijngaarden GK, Stam FC, et al. Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet 1982;2:1233-1237
50. Pruitt AA, Rubin RH, Karchmer AW, et al. Neurologic complications of bacterial endocarditis. Medicine (Baltimore) 1978;57:329-343
51. Ramsey RG, Gunnar RM, Tobin JR Jr. Endocarditis in the drug addict. Am J Cardiol 1970;25:608-618
52. Tunkel AR, Pradhan SK. Central nervous system infections in injection drug users. Infect Dis Clin North Am 2002;16:589-605
53. Falcone S, Post MJ. Encephalitis, cerebritis, and brain abscess: pathophysiology and imaging findings. Neuroimaging Clin N Am 2000;10:333-353 (Pubitemid 30313936)
54. Leuthardt EC, Wippold FJ 2nd, Oswood MC, et al. Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses. Surg Neurol 2002;58:395-402, discussion 402